Daniel B Soland's Net Worth

$10.7 Million

Estimate Recalculated Apr 22, 2024 03:38PM EST

Who is Daniel B Soland?

Daniel B Soland has an estimated net worth of $10.7 Million. This is based on reported shares across multiple companies, which include KalVista Pharmaceuticals, Inc., ACADIA PHARMACEUTICALS INC, IDERA PHARMACEUTICALS, INC., DBV Technologies S.A., VIROPHARMA INC, and CHIRON CORP.

SEC CIK

Daniel B Soland's CIK is 0001318485

Past Insider Trading and Trends

2012 was Daniel B Soland's most active year for acquiring shares with 6 total transactions. Daniel B Soland's most active month to acquire stocks was the month of May. 2014 was Daniel B Soland's most active year for disposing of shares, totalling 24 transactions. Daniel B Soland's most active month to dispose stocks was the month of December. 2013 saw Daniel B Soland paying a total of $1,027,486.24 for 221,732 shares, this is the most they've acquired in one year. In 2014 Daniel B Soland cashed out on 918,992 shares for a total of $7,881,088.60, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

KalVista Pharmaceuticals, Inc. (KALV) Snapshot price: $14.525

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Oct 1
Form 4
—
0
—
—
0
Oct 1
Form 4
∞
10K
$11.87
$118,749.99
10K
Sep 26 - Sep 27
Form 4
—
0
—
—
0
Apr 22
Form 3
—
0
—
—
0
No matching records found

ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $25.31

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+180.02%
18K
—
—
28K
Jun 22 - Jun 1
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 26
Form 4
—
0
—
—
0
Jun 6
Form 4
∞
10K
$23.49
$234,910.00
10K
Mar 1 - Mar 2
Form 4
—
0
—
—
0
Jul 17
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Mar 20
Form 3
—
0
—
—
0
No matching records found

IDERA PHARMACEUTICALS, INC. No price found

CHIEF OPERATING OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 6
Form 3
—
0
—
—
0
No matching records found

DBV Technologies S.A. (DBVT) Snapshot price: $0.908

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+300.00%
15K
$1.62
$24,300.00
20K
Aug 1
Form 4
—
0
—
—
0
Jun 10
Form 3
—
0
—
—
0
No matching records found

VIROPHARMA INC No price found

VP, Chief Operating Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-153.33K
$50.00
—
0
Jan 24
Form 4
+10.83%
14.98K
$29.63
-$32,266.53
153.33K
Jan 8
Form 4
+7.53%
9.69K
$27.89
-$22,231.74
138.35K
Dec 27
Form 4
+78.80%
56.7K
$28.84
-$2,227,967.18
128.66K
Dec 18
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jun 4
Form 4
+63.48%
27.22K
$21.30
$25.03
70.1K
Mar 9
Form 4
-41.16%
-30.00K
$32.99
-$989,700.00
42.88K
Mar 1
Form 4
—
0
—
—
0
Jan 5
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jan 5
Form 4
—
0
—
—
0
Jun 7
Form 4
+27.16%
20K
$12.22
$244,303.00
93.64K
May 6 - May 7
Form 4
—
0
—
—
0
Jan 7
Form 4
—
0
—
—
0
Jun 11
Form 4
+75.00%
30K
$4.05
$121,500.00
70K
Mar 12
Form 4
—
0
—
—
0
Jan 8
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jan 11
Form 4
+33.33%
10K
$7.26
$72,600.00
40K
Nov 7
Form 4
+100.00%
15K
$8.31
$124,650.00
30K
Nov 1
Form 4
∞
15K
$8.00
$120,000.00
15K
Aug 16
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jan 12
Form 4
—
0
—
—
0
Nov 6
Form 3
—
0
—
—
0
No matching records found